Early life programming as a target for prevention of child and adolescent mental disorders

BMC Medicine

Christos Symeonides²  Tara Gannon³  Megan Galbally¹  Andrew James Lewis³ 

[1] Department of Perinatal Mental Health, Mercy Hospital for Women, Melbourne, Australia;Murdoch Childrens Research Institute, Melbourne, Australia;School of Psychology, Faculty of Health, Deakin University, Melbourne, Australia

关键词: Teterogenic exposures;    Prevention;    Obesity;    Maternal mental health;    Fetal programming;    Developmental origins (DOHaD);    Child and adolescent mental health;   

Others  :  854970
DOI  :  10.1186/1741-7015-12-33

 received in 2013-10-09, accepted in 2014-01-21,  发布年份 2014

【 摘 要 】

This paper concerns future policy development and programs of research for the prevention of mental disorders based on research emerging from fetal and early life programming. The current review offers an overview of findings on pregnancy exposures such as maternal mental health, lifestyle factors, and potential teratogenic and neurotoxic exposures on child outcomes. Outcomes of interest are common child and adolescent mental disorders including hyperactive, behavioral and emotional disorders. This literature suggests that the preconception and perinatal periods offer important opportunities for the prevention of deleterious fetal exposures. As such, the perinatal period is a critical period where future mental health prevention efforts should be focused and prevention models developed. Interventions grounded in evidence-based recommendations for the perinatal period could take the form of public health, universal and more targeted interventions. If successful, such interventions are likely to have lifelong effects on (mental) health.

【 授权许可】

   
2014 Lewis et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Barker DJ: The developmental origins of chronic adult disease. Acta Paediatrica 2004, 93:26-33.
• [2]Belfer ML: Child and adolescent mental disorders: the magnitude of the problem across the globe. J Child Psychol Psychiatry 2008, 49:226-236.
• [3]Ravens-Sieberer U, Wille N, Erhart M, Bettge S, Wittchen HU, Rothenberger A, Herpertz-Dahlmann B, Resch F, Holling H, Bullinger M, Barkmann C, Schulte-Markwort M, Dopfner M, BELLA study group: Prevalence of mental health problems among children and adolescents in Germany: results of the BELLA study within the National Health Interview and Examination Survey. Eur Child Adolesc Psychiatry 2008, 17:22-33.
• [4]Sawyer MG, Arney FM, Baghurst PA, Clarke JJ, Graetz BW, Kosky RJ, Nurcomber B, Patton GC, Prior MR, Raphael B, et al.: The mental health of young people in Australia-key findings from the child and adolescent component of the national survey of mental health and well-being. Aust N Z J Psychiatry 2001, 35:806-814.
• [5]Merikangas KR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS: Prevalence and treatment of mental disorders among US children in the 2001–2004 NHANES. Pediatrics 2010, 125:75-81.
• [6]Meltzer H: Childhood mental disorders in Great Britain: an epidemiological perspective. Child Care Pract 2007, 13:313-326.
• [7]Rescorla L, Achenbach TM, Ivanova MY, Dumenci L, Almqvist F, Bilenberg N, Bird H, Broberg A, Dobrean A, Dopfner M, et al.: Epidemiological comparisons of problems and positive qualities reported by adolescents in 24 countries. J Consult Clin Psychol 2007, 75:351-358.
• [8]Angold A, Costello EJ, Worthman CM: Puberty and depression- the roles of age, pubertal status and pubertal timing. Psychol Med 1998, 28:51-61.
• [9]Mueller BR, Bale TL: Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci 2008, 28:9055-9065.
• [10]Barker DJ: The Wellcome Foundation Lecture, 1994. The fetal origins of adult disease. Proc Biol Sci 1995, 262:37-43.
• [11]Gluckman PD, Hanson MA: The developmental origins of health and disease: the breadth and importance of the concept. In Early Life Origins of Health and Disease. Edited by Wintour EM, Owens JA. New York, NY: Springer Science + Business Media; 2006.
• [12]Kieling C, Baker-Henningham H, Belfer M, Conti G, Ertem I, Omigbodun O, Rohde LA, Srinath S, Ulkuer N, Rahman A: Child and adolescent mental health worldwide: evidence for action. Lancet 2011, 378:1515-1525.
• [13]Stearns SC, Koella JC: The evolution of phenotypic plasticity in life-history traits: predictions of reaction norms for age and size at maturity. Evolution 1986, 40:893-913.
• [14]Gluckman PD, Hanson MA, Beedle AS: Early life events and their consequences for later disease: a life history and evolutionary perspective. Am J Hum Biol 2007, 19:1-19.
• [15]West-Eberhard MJ: Developmental Plasticity and Evolution. Oxford: Oxford University Press; 2003.
• [16]Gluckman PD, Hanson MA, Bateson P, Beedle AS, Law CM, Bhutta ZA, Anokhin KV, Bougnères P, Chandak GR, Dasgupta P, et al.: Towards a new developmental synthesis: adaptive developmental plasticity and human disease. Lancet 2009, 373:1654-1657.
• [17]Bateson P, Barker D, Clutton-Brock T, Deb D, D'Udine B, Foley R, Gluckman P, Godfrey K, Kirkwood T, Lahr M: Developmental plasticity and human health. Nature 2004, 430:419-421.
• [18]Gluckman PD, Hanson MA: The conceptual basis for the developmental origins of health and disease. In Developmental Origins of Health and Disease. Edited by Gluckman PD, Hanson MA. New York: Cambridge University Press; 2006:33-50.
• [19]Ollikainen M, Smith KR, Joo EJ-H, Ng HK, Andronikos R, Novakovic B, Aziz NKA, Carlin JB, Morley R, Saffery R: DNA methylation analysis of multiple tissues from newborn twins reveals both genetic and intrauterine components to variation in the human neonatal epigenome. Hum Mol Genet 2010, 19:4176-4188.
• [20]Meaney MJ, Szyf M, Seckl JR: Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends Mol Med 2007, 13:269-277.
• [21]Schlotz W, Phillips DI: Fetal origins of mental health: evidence and mechanisms. Brain Behav Immun 2009, 23:905-916.
• [22]Whitelaw E, Garrick D: Epigenetic mechanisms. In Developmental Origins of Health and Disease. Edited by Gluckman PD, Hanson MA. New York: Cambridge University Press; 2006:62-74.
• [23]Martino D, Loke YJ, Gordon L, Ollikainen M, Cruickshank MN, Saffery R, Craig JM: Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18 months of age reveals rapid epigenetic change in early life and pair-specific effects of discordance. Genome Biol 2013, 14:R42. BioMed Central Full Text
• [24]Barker DJ, Osmond C, Rodin I, Fall C, Winter P: Low weight gain in infancy and suicide in adult life. BMJ 1995, 311:1203.
• [25]Talge NM, Neal C, Glover V: Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry 2007, 48:245-261.
• [26]Swanson JD, Wadhwa PM: Developmental origins of child mental health disorders. J Child Psychol Psychiatry 2008, 49:1009-1019.
• [27]Lupien SJ, McEwen BS, Gunnar MR, Heim C: Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009, 10:434-445.
• [28]Bolt R, Van Weissenbruch M, Lafeber H, Delemarre-Van de Waal H: Development of the hypothalamic-pituitary-adrenal axis in the fetus and preterm infant. J Pediatr Endocrinol Metab 2002, 15:759-770.
• [29]Challis J, Sloboda D, Matthews S, Holloway A, Alfaidy N, Patel F, Whittle W, Fraser M, Moss T, Newnham J: The fetal placental hypothalamic–pituitary–adrenal (HPA) axis, parturition and post natal health. Mol Cell Endocrinol 2001, 185:135-144.
• [30]De Kloet ER, Joëls M, Holsboer F: Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005, 6:463-475.
• [31]Phillips DI, Jones A: Fetal programming of autonomic and HPA function: do people who were small babies have enhanced stress responses? J Physiol 2006, 572:45-50.
• [32]Price D, Close G, Fielding B: Age of appearance of circadian rhythm in salivary cortisol values in infancy. Arch Dis Child 1983, 58:454-456.
• [33]Gunnar M, Quevedo K: The neurobiology of stress and development. Annu Rev Psychol 2007, 58:145-173.
• [34]Cottrell EC, Seckl JR: Prenatal stress, glucocorticoids and the programming of adult disease. Front Behav Neurosci 2009, 3:1-9.
• [35]O'donnell K, O'connor T, Glover V: Prenatal stress and neurodevelopment of the child: focus on the HPA axis and role of the placenta. Dev Neurosci 2009, 31:285-292.
• [36]Monk C, Spicer J, Champagne FA: Linking prenatal maternal adversity to developmental outcomes in infants: the role of epigenetic pathways. Dev Psychopathol 2012, 24:1361-1376.
• [37]Schroeder JW, Smith AK, Brennan PA, Conneely KN, Kilaru V, Knight BT, Newport DJ, Cubells JF, Stowe ZN: DNA methylation in neonates born to women receiving psychiatric care. Epigenetics 2012, 7:409-414.
• [38]Smith AK, Conneely KN, Newport DJ, Kilaru V, Schroeder JW, Pennell PB, Knight BT, Cubells JC, Stowe ZN, Brennan PA: Prenatal antiepileptic exposure associates with neonatal DNA methylation differences. Epigenetics 2012, 7:458-463.
• [39]Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM: Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008, 3:97-106.
• [40]Nathanielsz PW, Nathanielsz P: Life in the Womb: The Origin of Health and Disease. Ithaca, NY: Promethean Press; 1999.
• [41]Barker DJ: Maternal nutrition, fetal nutrition, and disease in later life. Nutrition 1997, 13:807-813.
• [42]Bale TL, Baram TZ, Brown AS, Goldstein JM, Insel TR, McCarthy MM, Nemeroff CB, Reyes TM, Simerly RB, Susser ES: Early life programming and neurodevelopmental disorders. Biol Psychiatry 2010, 68:314-319.
• [43]Sullivan EL, Grayson B, Takahashi D, Robertson N, Maier A, Bethea CL, Smith MS, Coleman K, Grove KL: Chronic consumption of a high-fat diet during pregnancy causes perturbations in the serotonergic system and increased anxiety-like behavior in nonhuman primate offspring. J Neurosci 2010, 30:3826-3830.
• [44]Vucetic Z, Kimmel J, Totoki K, Hollenbeck E, Reyes TM: Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology 2010, 151:4756-4764.
• [45]Jacka FN, Ystrom E, Brantsaeter AL, Karevold E, Roth C, Haugen M, Meltzer HM, Schjolberg S, Berk M: Maternal and early postnatal nutrition and mental health of offspring by age 5 years: a prospective cohort study. J Am Acad Child Adolesc Psychiatr 2013, 52:1038-1047.
• [46]Keenan K, Bartlett TQ, Nijland M, Rodriguez JS, Nathanielsz PW, Zürcher NR: Poor nutrition during pregnancy and lactation negatively affects neurodevelopment of the offspring: evidence from a translational primate model. Am J Clin Nutr 2013, 98:396-402.
• [47]Rodriguez A: Maternal pre‒pregnancy obesity and risk for inattention and negative emotionality in children. J Child Psychol Psychiatry 2010, 51:134-143.
• [48]Van Lieshout RJ, Taylor VH, Boyle MH: Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: a systematic review. Obes Rev 2011, 12:e548-e559.
• [49]Goodman SH, Gotlib IH: Risk for psychopathology in the children of depressed mothers: a developmental model for understanding mechanisms of transmission. Psychol Rev 1999, 106:458-490.
• [50]Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ: A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010, 67:1012.
• [51]Murray L, Halligan SL, Goodyer I, Herbert J: Disturbances in early parenting of depressed mothers and cortisol secretion in offspring: a preliminary study. J Affect Disord 2010, 122:218-223.
• [52]Bagner DM, Pettit JW, Lewinsohn PM, Seeley JR: Effect of maternal depression on child behavior: a sensitive period? J Am Acad Child Adolesc Psychiatry 2010, 49:699-707.
• [53]Bureau JF, Easterbrooks MA, Lyons-Ruth K: Maternal depressive symptoms in infancy: unique contribution to children's depressive symptoms in childhood and adolescence? Dev Psychopathol 2009, 21:519-537.
• [54]Dawson G, Klinger LG, Panagiotides H, Hill D, Spieker S: Frontal lobe activity and affective behavior of infants of mothers with depressive symptoms. Child Dev 1992, 63:725-737.
• [55]Tronick EZ: Emotions and emotional communication in infants. Am Psychol 1989, 44:112-119.
• [56]Field T: Maternal depression effects on infants and early interventions. Prev Med 1998, 27:200-203.
• [57]Gotlib IH, Whiffen VE, Mount JH, Milne K, Cordy NI: Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol 1989, 57:269-274.
• [58]O'Hara MW, Swain AM: Rates and risk of postpartum degression - a meta-analysis. Int Rev Psychiatry 1996, 8:37-54.
• [59]Martins C, Gaffan EA: Effects of early maternal depression on patterns of infant-mother attachment: a meta-analytic investigation. J Child Psychol Psychiatry 2000, 41:737-746.
• [60]Weinstock M: The potential influence of maternal stress hormones on development and mental health of the offspring. Brain Behav Immun 2005, 19:296-308.
• [61]Van den Bergh BRH, Marcoen A: High antenatal maternal anxiety is related to ADHD symptoms, externalizing problems, and anxiety in 8- and 9-year-olds. Child Dev 2004, 75:1085-1097.
• [62]Bergman K, Sarkar P, Glover V, O'Connor TG: Maternal prenatal cortisol and infant cognitive development: moderation by infant-mother attachment. Biol Psychiatry 2010, 67:1026-1032.
• [63]Lewis AJ, Olsson CA: Early life stress and child temperament style as predictors of childhood anxiety and depressive symptoms: findings from the longitudinal study of Australian children. Depress Res Treat 2011, 2012:1-9.
• [64]Kaplan LA, Evans L, Monk C: Effects of mothers’ prenatal psychiatric status and postnatal caregiving on infant biobehavioral regulation: can prenatal programming be modified? Early Hum Dev 2008, 84:249-256.
• [65]O'Connor TG, Heron J, Golding J, Beveridge M, Glover V: Maternal antenatal anxiety and children's behavioural/emotional problems at 4 years: report from the Avon Longitudinal Study of Parents and Children. Br J Psychiatry 2002, 180:502-508.
• [66]Van den Bergh BRH, van Calster B, Smits T, van Huffel S, Lagae L: Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology 2008, 33:536-545.
• [67]Glover V: Annual research review: prenatal stress and the origins of psychopathology: an evolutionary perspective. J Child Psychol Psychiatry 2011, 52:356-367.
• [68]Van den Bergh BR, Mulder EJ, Mennes M, Glover V: Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review. Neurosci Biobehav Rev 2005, 29:237-258.
• [69]Räikkönen K, Seckl J, Pesonen A-K, Simons A, Van den Bergh B: Stress, glucocorticoids and liquorice in human pregnancy: programmers of the offspring brain. Stress 2011, 14:590-603.
• [70]Khashan AS, Abel KM, McNamee R, Pedersen MG, Webb RT, Baker PN, Kenny LC, Mortensen PB: Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch Gen Psychiatry 2008, 65:146-152.
• [71]Spauwen J, Krabbendam L, Lieb R, Wittchen HU, van Os J: Early maternal stress and health behaviours and offspring expression of psychosis in adolescence. Acta Psychiatr Scand 2004, 110:356-364.
• [72]Kinney DK, Miller AM, Crowley DJ, Huang E, Gerber E: Autism prevalence following prenatal exposure to hurricanes and tropical storms in Louisiana. J Autism Dev Disord 2008, 38:481-488.
• [73]Watson JB, Mednick SA, Huttunen M, Wang X: Prenatal teratogens and the development of adult mental illness. Dev Psychopathol 1999, 11:457-466.
• [74]Loomans EM, van der Stelt O, van Eijsden M, Gemke RJBJ, Vrijkotte T, van den Bergh BR: Antenatal maternal anxiety is associated with problem behaviour at age five. Early Hum Dev 2011, 87:565-570.
• [75]O'Connor TG, Heron J, Golding J, Glover V, the ALSPAC Study Team: Maternal antenatal anxiety and behavioural/ emotional problems in children: a test of a programming hypothesis. J Child Psychol Psychiatry 2003, 44:1025-1036.
• [76]Clavarino AM, Mamun AA, O'Callaghan M, Aird R, Bor W, O'Callaghan F, Williams GM, Marrington S, Najman JM, Alati R: Maternal anxiety and attention problems in children at 5 and 14 years. J Atten Disord 2010, 13:658-667.
• [77]Robinson M, Oddy WH, Li J, Kendall GE, de Klerk NH, Silburn SR, Zubrick SR, Newnham JP, Stanley FJ, Mattes E: Pre- and postnatal influences on preschool mental health: a large-scale cohort study. J Child Psychol Psychiatry 2008, 49:1118-1128.
• [78]Mayes LC, Ward A: Principles of neurobehavioral teratology. Neurodevelopmental Mech Psychopathol 2003, 3-33.
• [79]Obican S, Scialli AR: Teratogenic exposures. Am J Med Genet C Semin Med Genet 2011, 157C:150-169.
• [80]Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Lee D-H, Shioda T, Soto AM, vom Saal FS, Welshons WV: Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012, 33:378-455.
• [81]Lewis MW, Misra S, Johnson HL, Rosen TS: Neurological and developmental outcomes of prenatally cocaine-exposed offspring from 12 to 36 months. Am J Drug Alcohol Abuse 2004, 30:299-320.
• [82]McDonald SD, Walker M, Perkins SL, Beyene J, Murphy K, Gibb W, Ohlsson A: The effect of tobacco exposure on the fetal hypothalamic-pituitary-adrenal axis. Bjog 2006, 113:1289-1295.
• [83]Stene-Larsen K, Borge AIH, Vollrath ME: Maternal smoking in pregnancy and externalizing behavior in 18-month-old children: results from a population-based prospective study. J Am Acad Child Adolesc Psychiatr 2009, 48:283-289.
• [84]Lester BM, Bagner DM, Liu J, LaGasse LL, Seifer R, Bauer CR, Shankaran S, Bada H, Higgins RD, Das A: Infant neurobehavioral dysregulation: behavior problems in children with prenatal substance exposure. Pediatrics 2009, 124:1355-1362.
• [85]Ebrahim SH, Floyd RL, Merritt RK II, Decoufle P, Holtzman D: Trends in pregnancy-related smoking rates in the United States, 1987–1996. JAMA 2000, 283:361-366.
• [86]Ethen MK, Ramadhani TA, Scheuerle AE, Canfield MA, Wyszynski DF, Druschel CM, Romitti PA: Alcohol consumption by women before and during pregnancy. Matern Child Health J 2009, 13:274-285.
• [87]Cooper WO, Willy ME, Pont SJ, Ray WA: Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007, 196:544.
• [88]Pirkle JL, Brody DJ, Gunter EW, Kramer RA, Paschal DC, Flegal KM, Matte TD: The decline in blood lead levels in the United States. JAMA 1994, 272:284-291.
• [89]Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A, Kotimaa A, Moilanen I, Thomsen PH, Olsen J, Jarvelin MR: Maternal lifestyle factors in pregnancy risk of ADHD. Am J Psychiatr 2003, 160:1028-1040.
• [90]Rodriguez A, Bohlin G: Are maternal smoking and stress during pregnancy related to ADHD symptoms in children? J Child Psychol Psychiatry 2005, 46:246-254.
• [91]Tiesler CM, Chen CM, Sausenthaler S, Herbarth O, Lehmann I, Schaaf B, Kramer U, von Berg A, von Kries R, Wichmann HE, Heinrich J: Passive smoking and behavioural problems in children: results from the LISAplus prospective birth cohort study. Environ Res 2011, 111:1173-1179.
• [92]Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP: Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect 2006, 114:1904-1909.
• [93]Brion MJ, Victora C, Matijasevich A, Horta B, Anselmi L, Steer C, Menezes AM, Lawlor DA, Davey Smith G: Maternal smoking and child psychological problems: disentangling causal and noncausal effects. Pediatrics 2010, 126:e57-e65.
• [94]Hsieh CJ, Jeng SF, Su YN, Liao HF, Hsieh WS, Wu KY, Chen PC: CYP1A1 modifies the effect of maternal exposure to environmental tobacco smoke on child behavior. Nicotine Tob Res 2010, 12:1108-1117.
• [95]Liu J, Leung PW, McCauley L, Ai Y, Pinto-Martin J: Mother's environmental tobacco smoke exposure during pregnancy and externalizing behavior problems in children. Neurotoxicology 2013, 34:167-174.
• [96]Twardella D, Bolte G, Fromme H, Wildner M, von Kries R: Exposure to secondhand tobacco smoke and child behaviour - results from a cross-sectional study among preschool children in Bavaria. Acta Paediatr 2010, 99:106-111.
• [97]Ruckinger S, Rzehak P, Chen CM, Sausenthaler S, Koletzko S, Bauer CP, Hoffmann U, Kramer U, Berdel D, von Berg A, et al.: Prenatal and postnatal tobacco exposure and behavioral problems in 10-year-old children: results from the GINI-plus prospective birth cohort study. Environ Health Perspect 2010, 118:150-154.
• [98]Langley K, Heron J, Smith GD, Thapar A: Maternal and paternal smoking during pregnancy and risk of ADHD symptoms in offspring: testing for intrauterine effects. Am J Epidemiol 2012, 176:261-268.
• [99]Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M, Rutter M, Harold G: Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol Psychiatry 2009, 66:722-727.
• [100]Buschgens CJ, Swinkels SH, van Aken MA, Ormel J, Verhulst FC, Buitelaar JK: Externalizing behaviors in preadolescents: familial risk to externalizing behaviors, prenatal and perinatal risks, and their interactions. Eur Child Adolesc Psychiatry 2009, 18:65-74.
• [101]Streissguth AP, Barr HM, Sampson PD: Moderate prenatal alcohol exposure: effects on child IQ and learning problems at age 7 1/2 years. Alcohol Clin Exp Res 1990, 14:662-669.
• [102]Sood B, Delaney-Black V, Covington C, Nordstrom-Klee B, Ager J, Templin T, Janisse J, Martier S, Sokol RJ: Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. dose–response effect. Pediatrics 2001, 108:e34-e34.
• [103]Bada HS, Das A, Bauer CR, Shankaran S, Lester B, LaGasse L, Hammond J, Wright LL, Higgins R: Impact of prenatal cocaine exposure on child behavior problems through school age. Pediatrics 2007, 119:e348-e359.
• [104]Savage J, Brodsky NL, Malmud E, Giannetta JM, Hurt H: Attentional functioning and impulse control in cocaine-exposed and control children at age ten years. J Dev Behav Pediatr 2005, 26:42-47.
• [105]LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C, Arria A, Huestis MA, DellaGrotta S, Lin H, Danereau L, Lester BM: Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics 2012, 129:681-688.
• [106]Goldschmidt L, Day NL, Richardson GA: Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 2000, 22:325-336.
• [107]Day NL, Leech SL, Goldschmidt L: The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning. Neurotoxicol Teratol 2011, 33:129-136.
• [108]Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, Staffa JA, Platt R: Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008, 198:194. e191-195
• [109]Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C: Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006, 63:898-906.
• [110]Lewis AJ, Bailey C, Galbally M: Anti-depressant use during pregnancy in Australia: findings from the Longitudinal Study of Australian Children. Aust N Z J Public Health 2012, 36:487-488.
• [111]Malm H, Artama M, Gissler M, Ritvanen A: Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol 2011, 118:111.
• [112]Galbally M, Roberts M, Buist A: Mood stabilizers in pregnancy: a systematic review. Aust N Z J Psychiatry 2010, 44:967-977.
• [113]Einarson A, Boskovic R: Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 2009, 15:183-192.
• [114]Einarson A, Einarson TR: Maternal use of antipsychotics in early pregnancy: little evidence of increased risk of congenital malformations. Evid Based Ment Health 2009, 12:29.
• [115]Gentile S: Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects. Acta Psychiatr Scand 2011, 123:266-275.
• [116]Gentile S, Galbally M: Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review. J Affect Disord 2010, 128:1-9.
• [117]Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE: Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003, 142:402-408.
• [118]Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC: Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl) 2011, 217:211-219.
• [119]Galbally M, Lewis AJ, Buist A: Developmental outcomes of children exposed to antidepressants in pregnancy. Aust N Z J Psychiatry 2011, 45:393-399.
• [120]Mortensen J, Olsen J, Larsen H, Bendsen J, Obel C, Sørensen H: Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics. Eur J Epidemiol 2003, 18:769-771.
• [121]Weikum WM, Oberlander TF, Hensch TK, Werker JF: Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proc Natl Acad Sci 2012, 109:17221-17227.
• [122]Lewis A, Galbally M, Bailey C: Perinatal mental health, antidepressants and neonatal outcomes: findings from the Longitudinal Study of Australian Children. Neonatal Paediatr Child Health Nurs 2012, 15:22-28.
• [123]Galbally M, Snellen M, Lewis AJ: A review of the use of psychotropic medication in pregnancy. Current Opinion in Obstetrics and Gynecology 2011, 23:408-414.
• [124]Lewis AJ, Galbally M, Opie G, Buist A: Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication. Aust N Z J Psychiatry 2010, 44:482-487.
• [125]Galbally M, Lewis AJ, Lum J, Buist A: Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study. Aust N Z J Psychiatry 2009, 43:846-854.
• [126]Galbally M, Snellen M, Lewis AJ: A review of the use of psychotropic medication in pregnancy. Curr Opin Obstet Gynecol 2011. Publish Ahead of Print:10.1097/GCO.1090b1013e32834b32892f32833
• [127]Austin MP, Kildea S, Sullivan E: Maternal mortality and psychiatric morbidity in the perinatal period: challenges and opportunities for prevention in the Australian setting. Med J Aust 2007, 186:364-367.
• [128]Schnaas L, Rothenberg SJ, Flores M-F, Martinez S, Hernandez C, Osorio E, Velasco SR, Perroni E: Reduced intellectual development in children with prenatal lead exposure. Environ Health Perspect 2005, 114:791-797.
• [129]Wasserman GA, Staghezza-Jaramillo B, Shrout P, Popovac D, Graziano J: The effect of lead exposure on behavior problems in preschool children. Am J Public Health 1998, 88:481-486.
• [130]Dietrich KN, Ris MD, Succop PA, Berger OG, Bornschein RL: Early exposure to lead and juvenile delinquency. Neurotoxicol Teratol 2001, 23:511-518.
• [131]Tong S, Baghurst PA, Sawyer MG, Burns J, McMichael AJ: Declining blood lead levels and changes in cognitive function during childhood: the Port Pirie Cohort Study. JAMA 1998, 280:1915-1919.
• [132]Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP: Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 2003, 348:1517-1526.
• [133]Huang PC, Su PH, Chen HY, Huang HB, Tsai JL, Huang HI, Wang SL: Childhood blood lead levels and intellectual development after ban of leaded gasoline in Taiwan: a 9-year prospective study. Environ Int 2012, 40:88-96.
• [134]Chen A, Cai B, Dietrich KN, Radcliffe J, Rogan WJ: Lead exposure, IQ, and behavior in urban 5- to 7-year-olds: does lead affect behavior only by lowering IQ? Pediatrics 2007, 119:e650-e658.
• [135]Wasserman GA, Liu X, Popovac D, Factor-Litvak P, Kline J, Waternaux C, LoIacono N, Graziano JH: The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence. Neurotoxicol Teratol 2000, 22:811-818.
• [136]Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, Canfield RL, Dietrich KN, Bornschein R, Greene T, Rothenberg SJ, Needleman HL, Schnaas L, Wasserman G, Graziano J, Roberts R: Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 2005, 113:894-899.
• [137]Baghurst PA, McMichael AJ, Wigg NR, Vimpani GV, Robertson EF, Roberts RJ, Tong SL: Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study. N Engl J Med 1992, 327:1279-1284.
• [138]Chiodo LM, Jacobson SW, Jacobson JL: Neurodevelopmental effects of postnatal lead exposure at very low levels. Neurotoxicol Teratol 2004, 26:359-371.
• [139]Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB: Bone lead levels and delinquent behavior. JAMA 1996, 275:363-369.
• [140]Sciarillo WG, Alexander G, Farrell KP: Lead exposure and child behavior. Am J Public Health 1992, 82:1356-1360.
• [141]Burns JM, Baghurst PA, Sawyer MG, McMichael AJ, Tong SL: Lifetime low-level exposure to environmental lead and children's emotional and behavioral development at ages 11–13 years. The Port Pirie Cohort Study. Am J Public Health 1999, 149:740-749.
• [142]Froehlich TE, Lanphear BP, Auinger P, Hornung R, Epstein JN, Braun J, Kahn RS: Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics 2009, 124:e1054-e1063.
• [143]Symeonides C, Ponsonby A-L, Vuillermin P, Anderson V, Sly P: Environmental chemical contributions to ADHD and the externalising disorders of childhood - a review of epidemiological evidence. J Environ Immunol Toxicol 2013, 1:92-104.
• [144]Sagiv SK, Thurston SW, Bellinger DC, Amarasiriwardena C, Korrick SA: Prenatal exposure to mercury and fish consumption during pregnancy and attention-deficit/hyperactivity disorder-related behavior in children. Arch Pediatr Adolesc Med 2012, 166:1123-1131.
• [145]Sagiv SK, Thurston SW, Bellinger DC, Tolbert PE, Altshul LM, Korrick SA: Prenatal organochlorine exposure and behaviors associated with attention deficit hyperactivity disorder in school-aged children. Am J Epidemiol 2010, 171:593-601.
• [146]Wise A, Parham F, Axelrad DA, Guyton KZ, Portier C, Zeise L, Zoeller RT, Woodruff TJ: Upstream adverse effects in risk assessment: a model of polychlorinated biphenyls, thyroid hormone disruption and neurological outcomes in humans. Environ Res 2012, 117:90-99.
• [147]Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL, Brown MJ: Trends in blood lead levels and blood lead testing among US children aged 1 to 5 years, 1988–2004. Pediatrics 2009, 123:e376-e385.
• [148]Noren K, Meironyte D: Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20–30 years. Chemosphere 2000, 40:1111-1123.
• [149]Zietz BP, Hoopmann M, Funcke M, Huppmann R, Suchenwirth R, Gierden E: Long-term biomonitoring of polychlorinated biphenyls and organochlorine pesticides in human milk from mothers living in northern Germany. Int J Hyg Environ Health 2008, 211:624-638.
• [150]What are the trends in exposure to environmental contaminants including across population subgroups and geographic regions? [http://cfpub.epa.gov/eroe/index.cfm?fuseaction=detail.viewInd&lv=list.listbyalpha&r=224031&subtop=208 webcite]
• [151]Grandjean P, Landrigan PJ: Developmental neurotoxicity of industrial chemicals. Lancet 2006, 368:2167-2178.
• [152]Zhu SH, Valbo A: Depression and smoking during pregnancy. Addict Behav 2002, 27:649-658.
• [153]DiPietro JA, Novak MF, Costigan KA, Atella LD, Reusing SP: Maternal psychological distress during pregnancy in relation to child development at age two. Child Dev 2006, 77:573-587.
• [154]Way BM, Taylor SE: The serotonin transporter promoter polymorphism is associated with cortisol response to psychosocial stress. Biol Psychiatry 2010, 67:487-492.
• [155]Davis EP, Sandman CA: The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development. Child Dev 2010, 81:131-148.
• [156]Rayen I, van den Hove DL, Prickaerts J, Steinbusch HW, Pawluski JL: Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One 2011, 6:e24003.
• [157]Lee HJ, Kim JW, Yim SV, Kim MJ, Kim SA, Kim YJ, Kim CJ, Chung JH: Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats. Mol Psychiatry 2001, 6:610. 725–618
• [158]Weikum WM, Brain U, Chau CM, Grunau RE, Boyce WT, Diamond A, Oberlander TF: Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age. Front Cell Neurosci 2013, 7:180.
• [159]Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B: Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry 2012, 169:1165-1174.
• [160]Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G: Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002, 159:1889-1895.
• [161]Andrews G, Issakidis C, Sanderson K, Corry J, Lapsley H: Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry 2004, 184:526-533.
• [162]Jacka FN, Reavley NJ, Jorm AF, Toumbourou JW, Lewis AJ, Berk M: Prevention of common mental disorders: What can we learn from those who have gone before and where do we go next? Aust N Z J Psychiatry 2013, 47:920-929.
• [163]Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, Rahman A: No health without mental health. Lancet 2007, 370:859-877.
• [164]Olds DL, Sadler L, Kitzman H: Programs for parents of infants and toddlers: recent evidence from randomized trials. J Child Psychol Psychiatr 2007, 48:355-391.
• [165]Olds DL, Kitzman H, Hanks C, Cole R, Anson E, Sidora-Arcoleo K, Luckey DW, Henderson CR, Holmberg J, Tutt RA: Effects of nurse home visiting on maternal and child functioning: age-9 follow-up of a randomized trial. Pediatrics 2007, 120:e832-e845.
• [166]Olds DL: The nurse-family partnership: an evidence-based preventive intervention. Infant Ment Health J 2006, 27:5-25.
• [167]Dennis CL: Psychosocial and psychological interventions for prevention of postnatal depression: systematic review. BMJ 2005, 331:15.
• [168]Fisher JR, Wynter KH, Rowe HJ: Innovative psycho-educational program to prevent common postpartum mental disorders in primiparous women: a before and after controlled study. BMC Publ Health 2010, 10:432. BioMed Central Full Text
• [169]Lumley J, Austin MP, Mitchell C: Intervening to reduce depression after birth: a systematic review of the randomized trials. Int J Technol Assess Health Care 2004, 20:128-144.